Kidney. UK RPG: The UK Renal Pharmacy Group. Chronic kidney disease: managing anaemia. This guideline updates and replaces NICE guideline CG114 (published February 2011).
It offers evidence-based advice on diagnosing and managing anaemia of chronic kidney disease. In this update, new recommendations have been added on diagnosis and management, including the detection and management of ESA-resistant anaemia. This guideline was previously called anaemia management in people with chronic kidney disease. Your responsibility. Chronic kidney disease in adults: assessment and management. Next review date: June 2017 Go straight to the recommendations This guideline offers evidence-based advice on the care and treatment of people with chronic kidney disease.
Chronic kidney disease (stage 4 or 5): management of hyperphosphataemia. Review decision date: December 2014 Review decision: Following the recent surveillance review which checks the need to update CG157, this guideline should not be updated at this time.
Kidney International. IMPROVING GLOBAL OUTCOMES. UK RPG: The UK Renal Pharmacy Group. Kidney Stone Remedies Research & Treatment – KidneyAtlas.org. The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI ) - The National Kidney Foundation. The National Kidney Foundation produces clinical practice guidelines through the NKF Kidney Disease Outcomes Quality Initiative (NKF KDOQI)™.
This program has provided evidence-based guidelines for all stages of chronic kidney disease (CKD) and related complications since 1997. Recognized throughout the world for improving the diagnosis and treatment of kidney disease, the KDOQI guidelines have changed the practices of numerous specialties and disciplines and improved the lives of thousands of kidney patients. All KDOQI Guidelines and Commentaries are published in the American Journal of Kidney Diseases (AJKD), NKF's premier journal. In addition to guideline development, KDOQI aims to improve clinical practice through collaboration with wider policy and education programs designed to support implementation of guideline recommendations.
Guidelines and Commentaries. IKA. A Guide to Kidney Transplantation - Beaumont Hospital. Nephrology - Renal Medicine - Cork University Hospital. Welcome to The Department of Renal Medicine at Cork University Hospital one of the country’s largest centres for patients with kidney disease.
We provide a full range of specialist treatments for patients with kidney disease and have a dedicated team based within the hospital and provide outreach services at Kerry General Hospital. Our main priority is the needs of our patients and their families. We are dedicated to improving outcomes for our patients and to ensuring their comfort. Cork University Hospital’s Cardiac Renal Centre was opened in 2010.
Spanning 13,000m2 over 6 floors, the Centre represents an innovative service development recognising the key interdependencies of the specialties of Cardiology, Cardiothoracic Surgery and Renal Medicine. Immunosuppressive therapy for renal transplantation in adults. NICE has made the following recommendations about the use of immunosuppressive drugs in adults receiving kidney transplants: Doctors should consider using basiliximab or daclizumab for induction treatment (immediately after the kidney transplant).
These drugs should be used with a combination of other drugs including a calcineurin inhibitor such as ciclosporin. The cheapest one of the two (basiliximab or daclizumab) should be used.